Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02244099 · ClinicalTrials.gov registry record · NA

Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic

A NA study of Anxiety and Chronic Pain, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
96
Enrollment target
1
Study location

NCT02244099 is a NA study of Anxiety and Chronic Pain that has completed, run by Ohio State University. The registered enrollment target is 96 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02244099, a NA study of Anxiety and Chronic Pain, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to characterize and improve controlled substance, carisoprodol and tramadol use in an internal medicine residents' clinic. Specific objectives of this study include: * To measure the adherence to a controlled substance treatment agreement (CSTA) before and after implementation of a population management intervention * To determine the number of patients on a CSTA with a discrepancy identified on a urine drug screen or an Ohio Automated Rx Reporting System (OARRS) report * To track the number of patients on a morphine equivalent dose (MED) of ≥ 80 mg/day before and after implementation of a review intervention * To characterize the healthcare utilization of patients taking controlled substances, carisoprodol, or tramadol by tracking the mean number of ED visits, hospital admissions, telephone calls, and clinic office visits during a 6 month period

Interventions

  • OTHER Controlled Substance

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2014-09
Est. Completion 2015-03
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT02244099

The ClinicalTrials.gov registry entry for NCT02244099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Controlled Substance is the first listed.

NCT02244099 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02244099 about?

NCT02244099 is a clinical study titled "Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic". The purpose of this study is to characterize and improve controlled substance, carisoprodol and tramadol use in an internal medicine residents' clinic. Specific objectives of this study include: * To measure the adherence to a controlled substance treatment agreement (CSTA) before and after impleme...

What is the current status of trial NCT02244099?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2014-09. Estimated completion is 2015-03.

What conditions does trial NCT02244099 study?

This clinical trial studies the following conditions: Anxiety, Chronic Pain, Opioid Use, Unspecified.

What interventions are being tested in trial NCT02244099?

The interventions under investigation include: Controlled Substance (OTHER).

Who is sponsoring clinical trial NCT02244099?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02244099 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.